Your browser doesn't support javascript.
loading
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
Kroese, Tiuri E; van Rossum, Peter S N; Nilsson, Magnus; Lordick, Florian; Smyth, Elizabeth C; Rosati, Riccardo; Nafteux, Philippe; D'Ugo, Domenico; Chaudry, M Asif; Polkowkski, Wojciech; Roviello, Franco; Gockel, Ines; Kolodziejczyk, Piotr; Haustermans, Karin; Guckenberger, Matthias; Nordsmark, Marianne; Hawkins, Maria A; Cervantes, Andres; Fleitas, Tania; van Cutsem, Eric; Moehler, Markus; Wagner, Anna D; van Laarhoven, Hanneke W M; van Hillegersberg, Richard.
Afiliación
  • Kroese TE; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • van Rossum PSN; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Nilsson M; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Lordick F; Department of Medical Oncology, University Cancer Center Leipzig, Leipzig University Medical Center, Leipzig, Germany.
  • Smyth EC; Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Hill's Road, Cambridge, UK.
  • Rosati R; Department of Gastrointestinal Surgery, San Raffaele Hospital, Milan, Italy.
  • Nafteux P; Department of Surgery, Katholieke Universiteit Leuven, Leuven, Belgium.
  • D'Ugo D; General Surgery Department, Policlinico Gemelli University Hospital, Rome, Italy.
  • Chaudry MA; Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, UK.
  • Polkowkski W; Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland.
  • Roviello F; Unit of General Surgery and Surgical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Gockel I; Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.
  • Kolodziejczyk P; Department of Surgery, Jagiellonian University Medical College, Krakow, Poland.
  • Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Belgium.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Nordsmark M; Department of Medical Oncology, Aarhus University, Aarhus, Denmark.
  • Hawkins MA; Cancer Institute, University College London, London, UK.
  • Cervantes A; Department of Medical Oncology, Biomedical Research Institute, INCLIVA, University of Valencia, Spain.
  • Fleitas T; Department of Medical Oncology, Biomedical Research Institute, INCLIVA, University of Valencia, Spain.
  • van Cutsem E; Department of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Moehler M; Medical Department, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Wagner AD; Department of Oncology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
  • van Laarhoven HWM; Department of Medical Oncology, University Medical Centers Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
  • van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: R.vanHillegersberg@umcutrecht.nl.
Eur J Surg Oncol ; 49(1): 21-28, 2023 01.
Article en En | MEDLINE | ID: mdl-36184420
ABSTRACT

BACKGROUND:

A uniform definition and treatment for oligometastatic esophagogastric cancer is currently lacking. However, a comprehensive definition of oligometastatic esophagogastric cancer is necessary to initiate studies on local treatment strategies (e.g. metastasectomy or stereotactic radiotherapy) and new systemic therapy agents in this group of patients. For this purpose, the OligoMetastatic Esophagogastric Cancer (OMEC) project was established. The OMEC-project aims to develop a multidisciplinary European consensus statement on the definition, diagnosis, and treatment for oligometastatic esophagogastric cancer and provide a framework for prospective studies to improve outcomes of these patients.

METHODS:

The OMEC-project consists of five studies, including 1) a systematic review on definitions and outcomes of oligometastatic esophagogastric cancer; 2) real-life clinical scenario discussions in multidisciplinary expert teams to determine the variation in the definition and treatment strategies; 3) Delphi consensus process through a starting meeting, two Delphi questionnaire rounds, and a consensus meeting; 4) publication of a multidisciplinary European consensus statement; and 5) a prospective clinical trial in patients with oligometastatic esophagogastric cancer.

DISCUSSION:

The OMEC project aims to establish a multidisciplinary European consensus statement for oligometastatic esophagogastric cancer and aims to initiate a prospective clinical trial to improve outcomes for these patients. Recommendations from OMEC can be used to update the relevant guidelines on treatment for patients with (oligometastatic) esophagogastric cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudio: Guideline / Observational_studies / Qualitative_research / Systematic_reviews Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudio: Guideline / Observational_studies / Qualitative_research / Systematic_reviews Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article